News &amp; Updates

Gay men and bisexual individuals are more likely to have risky sexual behaviours and experience sexual victimization, sexual dysfunctions, and other adverse outcomes than lesbians, reports a Danish study.

CCBs not associated with variceal haemorrhage in cirrhosis

Patients with cirrhosis using calcium channel blockers (CCBs) are not at increased risk of variceal haemorrhage, as reported in a retrospective study.

Telitacicept reduces proteinuria in adults with IgA nephropathy

29 Nov 2025 by

Treatment with telitacicept led to a significant reduction in proteinuria among patients with immunoglobulin A nephropathy (IgAN) compared with placebo, according to a phase III study presented at ASN Kidney Week 2025.

Resistance training may help people with long COVID

For individuals with persisting COVID-19 symptoms, a 3-month resistance exercise program appears to yield greater improvements in physical function and psychological well-being compared with usual care alone, as shown in a study.

GLP-1 RAs reduce deaths, MACE in at-risk individuals

Treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) results in a decrease in deaths and major adverse cardiovascular events (MACE) in high-risk patients, reports as study.

Behavioural problems prevalent in kids with adverse childhood experiences

Exposure to adverse childhood experiences (ACEs) appears to result in developmental, academic, and behavioural concerns among kindergarten children, suggests a Singapore study.

Repeat POEM works well against persistent achalasia symptoms

Patients with persistent symptoms of achalasia may benefit from repeat per-oral endoscopic myotomy (POEM) following a failed initial procedure, suggests a study.

Sparsentan remains superior to irbesartan for IgAN in post hoc analysis

In the post hoc analysis of the phase III PROTECT trial, the non-immunosuppressive dual endothelin angiotensin receptor antagonist sparsentan remains superior to irbesartan for the treatment of immunoglobulin A nephropathy (IgAN).

Stopping GLP-1RAs before or shortly after conception ups pregnancy complications

Discontinuing treatment with GLP-1RAs before or early into pregnancy in women with obesity may lead to more gestational weight gain and increased risk of preterm delivery, gestational diabetes, and hypertensive disorders of pregnancy, according to a retrospective study.

Mortality in first-time psychosis: 25-year study sheds light on trajectories & at-risk groups

In patients with first-episode psychosis, the cumulative incidence of unnatural deaths (mostly suicide) rises sharply during the first 10 years, while deaths from natural causes begin to increase after the first decade, a 25-year population-based cohort study in Hong Kong has shown.